Servier

190 articles about Servier

• Servier Initiates Phase 2 Study Of Gevokizumab In Patients With Diabetic Nephropathy

  4/1/2015

• Novo Nordisk A/S,Takeda, Servier, Celgene Among Top Sponsors Rated By Investigative Sites In New CenterWatch Inc. Survey

  3/2/2015

• ARMGO Pharma Inc. And Servier Announce Advancement Of Rycal ARM210/S48168 Into Clinical Stage Program Targeting Duchenne Muscular Dystrophy

  12/4/2014

• GeNeuro, Servier Ink $455M MS Drug Pact

  12/2/2014

• Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine)

  11/21/2014

• Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device

  11/13/2014

• Bay Area's Pharmacyclics, Inc. Stock Slumps After Ending Servier Collaboration

  9/26/2014

• CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize Pixuvri®

  9/17/2014

• Servier Breaches Code By Not Disclosing Clinical Trial Data

  9/9/2014

• Amgen, Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study

  9/4/2014

• Galapagos NV Receives Milestone In Osteoarthritis Alliance With Servier

  8/5/2014

• Vernalis PLC And Servier Achieve Two Research Milestones In Their Oncology Collaborations

  8/4/2014

• Servier To Teva Pharmaceutical Industries Limited Fined $582.2 Million on Generic Delays

  7/9/2014

• BioInvent Has Received Milestones From Bayer Pharma S.A. And Servier

  7/7/2014

• Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease

  6/23/2014

• EU Regulator To Fine Servier, Teva Pharmaceutical Industries Limited For Delaying Generic Drugs

  6/20/2014

• Vernalis PLC And Servier Achieve Research Milestone As BCL-2 Inhibitor Drug Candidate Enters Phase I

  6/19/2014

• Galapagos NV Receives EU2 Million From Osteoarthritis Alliance With Servier

  3/7/2014

• Celladon Corporation Announces Option Agreement With Servier

  2/24/2014

• Cellectis, Servier Forge Leukemia, Solid Tumors Pact To Battle With Novartis AG And Newbie Juno Therapeutics

  2/18/2014